Oncology & Cancer

Ovarian cancer patients survive longer with BRCA2 mutated in tumors

Women with high-grade ovarian cancer live longer and respond better to platinum-based chemotherapy when their tumors have BRCA2 genetic mutations, researchers at The University of Texas MD Anderson Cancer Center and the Institute ...

Oncology & Cancer

Scientists harness 'helper' T cells to treat tumors

Scientists are on the hunt for a unique set of mutations, called "neoantigens," that let the immune system distinguish tumor cells from normal cells. Their goal is to help the immune system react to neoantigens and target ...

Oncology & Cancer

Is your melanoma hot enough for immunotherapy?

Melanomas tend to be "hot" or "cold—if they're hot, immunotherapy lights melanoma tumors like beacons for elimination by the immune system; but 40-50 percent of melanomas are cold, making them invisible to the immune system, ...

page 15 from 40